The Trump administration issued a waiver to allow the continuation of lifesaving HIV medications through the President’s Emergency Plan for AIDS relief, following a recent halt to the program, The New York Times reported Jan. 28.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
